Smoking Prevalence in Harlem, New York

Resnicow, Ken; Futterman, Robert; Weston, R. Eric; Royce, Jacqueline; Parms, Clifford A.; Freeman, Harold P.; Orlandi, Mario

doi:10.4278/0890-1171-10.5.343

Cited by 23 publications

(7 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Definition of smokers were: (i) "those smoking every day" 27 ; (ii) "subjects who smoke daily or sometimes at the time of examination" 28,29,30,31 ; and (iii) "smoking one or more cigarettes weekly for 6 months or more before the survey" 32 .…”

Section: Resultsmentioning

confidence: 99%

Tobacco use among the elderly: a systematic review and meta-analysis

et al. 2010

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Tobacco use among the elderly: a systematic review and meta-analysis

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Knowing which factors predict adoption of HSR will assist in developing targeted intervention strategies that facilitate its adoption by households that would otherwise not have adopted one, especially in the inner city, where the prevalence of smoking is high and the living con- ditions crowded. 17 Therefore, we analyzed data from innercity black smokers enrolled in a smoking cessation study and tested the specific hypothesis that, in households of smokers without HSR at enrollment, the presence of children or a nonsmoking partner in the home will predict the future adoption of one.…”

mentioning

confidence: 99%

Predicting Adoption of Home Smoking Restriction by Inner-city Black Smokers

Okah¹,

Okuyemi²,

McCarter³

et al. 2003

Arch Pediatr Adolesc Med

View full text Add to dashboard Cite

show abstract

“…African Americans living in the inner city, for example, have a smoking rate as high as 45% while the general population's smoking rate is 25%. 1,2 The higher smoking rate among this population is not for lack of motivation to quit. In fact, compared with whites, African Americans are more likely to attempt to quit smoking more times in any given year.…”

mentioning

confidence: 99%

Sustained-Release Bupropion for Smoking Cessation in African Americans

Ahluwalia

Harris²,

Catley³

et al. 2002

JAMA

229

191

View full text Add to dashboard Cite

Context African Americans disproportionately experience greater smoking attributable morbidity and mortality. Few clinical trials for smoking cessation in African Americans have been conducted, despite a different profile of both smoking and quitting patterns.Objective To compare a sustained-release form of bupropion hydrochloride (bupropion SR) with placebo for smoking cessation among African Americans.Design, Setting, and Participants Randomized, double-blind, placebocontrolled trial conducted from February 11, 1999, to December 8, 2000, of 600 African American adults treated at a community-based health care center. Volunteers, who smoked 10 or more cigarettes per day were recruited by targeted media and health care professionals.Intervention Participants were randomly assigned to receive 150 mg of bupropion SR (n=300) or placebo (n=300) twice daily for 7 weeks. Brief motivational counseling was provided in-person at baseline, quit day, weeks 1 and 3, end of treatment (week 6), and by telephone at day 3 and weeks 5 and 7.Main Outcome Measures Biochemically confirmed 7-day point prevalence abstinence at weeks 6 and 26 following quit day. ResultsUsing intention-to-treat procedures, confirmed abstinence rates at the end of 7 weeks of treatment were 36.0% in the bupropion SR group and 19.0% in the placebo group (17.0 percentage point difference; 95% confidence interval, 9.7-24.4; PϽ.001). At 26 weeks the quit rates were 21.0% in the treatment and 13.7% in the placebo groups (7.3 percentage point difference; 95% confidence interval, 1.0-13.7; P=.02). Those taking bupropion SR experienced a greater mean reduction in depression symptoms at week 6 (2.96 [9.45] vs 1.13 [8.84]) than those taking placebo, and after controlling for continuous abstinence, those taking bupropion SR also gained less weight than those taking placebo.Conclusions Bupropion SR was effective for smoking cessation among African Americans and may be useful in reducing the health disparities associated with smoking.

show abstract

Smoking Prevalence in Harlem, New York

Cited by 23 publications

References 21 publications

Tobacco use among the elderly: a systematic review and meta-analysis

Tobacco use among the elderly: a systematic review and meta-analysis

Predicting Adoption of Home Smoking Restriction by Inner-city Black Smokers

Sustained-Release Bupropion for Smoking Cessation in African Americans

Contact Info

Product

Resources

About